A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...

Researchers have found in a 3-year phase 3 trial that palopegteriparatide (TransCon PTH) showed sustained improvements in ...

IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the TrilogyTM Transcatheter Heart Valve (THV) System, today announced that patient ...

Five individuals (3.3%) experienced peak aminotransferase levels greater than five times the ULN, and two (1.3%) had ...

In the first placebo-controlled study of vaporized cannabis for acute migraine, patients report greater relief from pain and ...

BiomX Inc. (AMEX:PHGE) saw its stock jump 60% after announcing the commencement of patient dosing in its Phase 2b clinical ...

Milestone payment of $10 million triggered under the global license agreement with TakedaLEXINGTON, Mass., July 17, 2025 ...

In this randomized, placebo-controlled trial, we investigated the effect of antenatal trimethoprim–sulfamethoxazole administration on infant birth outcomes in Zimbabwe, where preterm birth ...

A randomized, controlled trial may use another vaccine. For their dataset, Scott said they considered a trial placebo-controlled only if the placebo didn’t contain an antigen — the active ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating ...